mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.05 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.05 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.05 |